European Archives - Page 1104 of 1132 - European Medical Journal

Emerging Options for Patients with Atrial Fibrillation

Dr Jeffrey Weitz chaired the symposium and welcomed Dr Christian Ruff, who discussed and summarised recent results from key trials of new oral…

Meeting the Challenges in Atrial Fibrillation Management: The Role of New Anticoagulants

Prof Gregory Lip opened the symposium with a discussion on determining stroke and bleeding risk in atrial fibrillation (AF) patients and their management.

Premature Heart Attacks: Bad Lifestyle, Bad Luck, or Bad Genes?

Homozygous familial hypercholesterolaemia (HoFH), a rare inherited lipid disorder usually caused by bi-allelic defects in the LDLR gene, is characterised…

Imaging During Transcatheter Interventions for Valvular Heart Disease

Valvular heart disease is a growing field, and the number of new approaches for percutaneous treatment is increasing rapidly. These procedures usually…

Red Cell Distribution Width for Predicting Cardiovascular Disease: A Literature Review

Although the classical risk factors for cardiovascular disease (CVD) are very important, identification of potential novel risk factors could help…

Case Report: Double Orifice Mitral Valve with Cleft in Anterior Leaflet of Dominant Valve in an Afro-Caribbean

Double orifice mitral valve (DOMV) is a rare congenital mitral valve (MV) disorder. It is associated with other types of congenital heart disease in 45%…

The Quest for a Medical Treatment of Aortic Stenosis: Putative Therapeutic Targets

Aortic stenosis (AS), i.e. calcification and obstruction of the aortic valve (AV), is the most common type of valvular heart disease. The therapeutic…

Factors Affecting Serum Paraoxonase 1 Activity in Migrant and Resident Gujarati South Asians

Paraoxonase 1 (PON1) protects against the development of atherosclerosis by hydrolysing damaging lipid peroxides formed in low-density lipoprotein (LDL)…

Rationale for Promising Novel Therapeutic Approach Focused On Endothelin Pathway for Peripheral Arterial Disease

There is evidence to suggest that endothelin (ET-1) is involved in the pathophysiology of peripheral arterial disease (PAD), contributing to…

Current Controversies in Infective Endocarditis

Infective endocarditis (IE) remains a devastating disease with a high mortality. Its microbiology is changing with increasing incidence of Staphylococcus…